AIM ImmunoTech (AIM) Enterprise Value (2018 - 2025)
Historic Enterprise Value for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to -$2.4 million.
- ImmunoTech's Enterprise Value rose 6655.1% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 6655.1%. This contributed to the annual value of -$4.0 million for FY2024, which is 6957.15% up from last year.
- Per ImmunoTech's latest filing, its Enterprise Value stood at -$2.4 million for Q3 2025, which was up 6655.1% from -$835000.0 recorded in Q2 2025.
- Over the past 5 years, ImmunoTech's Enterprise Value peaked at -$835000.0 during Q2 2025, and registered a low of -$28.4 million during Q2 2023.
- Over the past 3 years, ImmunoTech's median Enterprise Value value was -$8.6 million (recorded in 2024), while the average stood at -$10.2 million.
- As far as peak fluctuations go, ImmunoTech's Enterprise Value surged by 6457.14% in 2024, and later soared by 9170.06% in 2025.
- Quarter analysis of 3 years shows ImmunoTech's Enterprise Value stood at -$13.1 million in 2023, then soared by 69.57% to -$4.0 million in 2024, then skyrocketed by 39.43% to -$2.4 million in 2025.
- Its Enterprise Value stands at -$2.4 million for Q3 2025, versus -$835000.0 for Q2 2025 and -$2.2 million for Q1 2025.